In line with these data, inactivation of components of the IFNGR pathway and antigen presentation machinery were identified in recent CRISPR-based genetic screens aimed at the unbiased exploration of tumor cell resistance mechanisms towards T cell attack [8–11]. The gene discussed is IFNGR1; the disease is neoplasm.